Bromocriptine

Products Bromocriptine is commercially available in tablet form (Parlodel). It was developed at Sandoz in the 1960s and has been approved in many countries since 1975. Generic versions are now available in many countries. Structure and properties Bromocriptine (C32H40BrN5O5, Mr = 654.6 g/mol) is a brominated derivative of the natural ergot alkaloid ergocryptine. It is … Bromocriptine

Drugs for dementia

Introduction Only in a few cases is it possible to treat the cause of dementia. Nevertheless, the use of medication can help many patients. They are used to improve the dementia patient’s mental performance and make it easier for him or her to cope with everyday life. Behavioural disorders can also be alleviated by medication. … Drugs for dementia

Apomorphine

Products Uprima sublingual tablets (2 mg, 3 mg) for erectile dysfunction are no longer marketed in many countries. The marketing authorization was not renewed by Abbott AG in 2006. Commercial reasons were cited, probably attributed to competition from phosphodiesterase-5 inhibitors (e.g., sildenafil, Viagra). It is also possible that a post-marketing study had played a role, … Apomorphine

Paliperidone

Products Paliperidone is commercially available as sustained-release tablets (Invega, generic) and as a sustained-release suspension for intramuscular injection (Xeplion, Trevicta, generic). It has been approved in many countries since 2008. Structure and properties Paliperidone (C23H27FN4O3, Mr = 426.5 g/mol) exists as a racemate and is practically insoluble in water. It belongs to the group of … Paliperidone

Parkinson’s syndrome

Definition A Parkinson’s syndrome is a clinical picture with typical symptoms that restrict movement. These symptoms are immobility (akinesia) or slowed movement, muscle rigidity (rigor), muscle tremor (rest tremor) and postural instability (postural instability). The symptoms are caused by a lack of dopamine, a neurotransmitter that controls movement in the brain. The symptoms do not … Parkinson’s syndrome

Life expectancy with a Parkinson’s syndrome | Parkinson’s syndrome

Life expectancy with a Parkinson’s syndrome Patients with Parkinson’s disease can have a normal life expectancy with good therapy! In the first ten years, the first fluctuations in the effect of the drugs occur. Within about 20 years of the disease, most of those affected are in need of care. In most cases, the causes … Life expectancy with a Parkinson’s syndrome | Parkinson’s syndrome

Rotigotine

Products Rotigotine is commercially available as a transdermal patch in various potencies (Neupro). It was approved in many countries in 2006 as the first TTS for Parkinson’s disease therapy. Structure and properties Rotigotine (C19H25NOS, Mr = 315.5 g/mol) is an aminotetralin and thiophene derivative structurally related to dopamine. It has a non-ergoline structure and exists … Rotigotine

Pergolide

Products Pergolide (Permax) had been approved in tablet form in many countries since 1997. On Sept. 30, 2011, Permax went off the market in many countries. The reason given for the market withdrawal was a fire at the packaging plant. Other dopamine agonists are available as alternatives. Structure and properties Pergolide (C19H26N2S, Mr = 314.5 … Pergolide

Ropinirole

Products Ropinirole is commercially available in the form of film-coated tablets (Adartrel, Requip, generic). It has been approved in many countries since 1996. Structure and properties Ropinirole (C16H24N2O, Mr = 260.4 g/mol) is a non-ergoline dopamine agonist and a dihydroindolone derivative. It is present in drugs as ropinirole hydrochloride, a white to yellow powder that … Ropinirole